Mankind Pharma Future Growth
Future criteria checks 3/6
Mankind Pharma is forecast to grow earnings and revenue by 15.7% and 11.7% per annum respectively. EPS is expected to grow by 15.8% per annum. Return on equity is forecast to be 20.3% in 3 years.
Key information
15.7%
Earnings growth rate
15.8%
EPS growth rate
| Pharmaceuticals earnings growth | 17.3% |
| Revenue growth rate | 11.7% |
| Future return on equity | 20.3% |
| Analyst coverage | Good |
| Last updated | 15 Jul 2024 |
Recent future growth updates
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Mankind Pharma Limited (NSE:MANKIND)
Jul 12
Here's Why Mankind Pharma (NSE:MANKIND) Has Caught The Eye Of Investors
May 08Mankind Pharma Limited's (NSE:MANKIND) Business Is Trailing The Market But Its Shares Aren't
Apr 08Mankind Pharma Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 147,286 | 30,905 | 27,812 | 30,031 | 8 |
| 3/31/2026 | 131,563 | 26,259 | 22,712 | 27,493 | 13 |
| 3/31/2025 | 116,275 | 22,100 | 18,592 | 24,135 | 12 |
| 3/31/2024 | 103,348 | 19,129 | 17,701 | 21,524 | N/A |
| 12/31/2023 | 99,463 | 17,271 | N/A | N/A | N/A |
| 9/30/2023 | 94,303 | 15,575 | 14,862 | 20,644 | N/A |
| 6/30/2023 | 91,481 | 14,762 | N/A | N/A | N/A |
| 3/31/2023 | 87,494 | 12,819 | 9,812 | 18,133 | N/A |
| 12/31/2022 | 84,225 | 11,865 | -15,564 | 10,901 | N/A |
| 3/31/2022 | 77,816 | 14,335 | -14,257 | 9,198 | N/A |
| 3/31/2021 | 62,144 | 12,654 | 8,249 | 11,372 | N/A |
| 3/31/2020 | 58,719 | 10,304 | 8,442 | 10,722 | N/A |
| 3/31/2019 | 49,800 | 5,785 | 3,027 | 6,004 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MANKIND's forecast earnings growth (15.7% per year) is above the savings rate (6.7%).
Earnings vs Market: MANKIND's earnings (15.7% per year) are forecast to grow slower than the Indian market (15.9% per year).
High Growth Earnings: MANKIND's earnings are forecast to grow, but not significantly.
Revenue vs Market: MANKIND's revenue (11.7% per year) is forecast to grow faster than the Indian market (9.7% per year).
High Growth Revenue: MANKIND's revenue (11.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MANKIND's Return on Equity is forecast to be high in 3 years time (20.3%)